Experience
Dr Reddy’s Laboratories (UK) Limited v. Boehringer Ingelheim International GmbH*
Dr Reddy’s Laboratories (UK) Limited
Boehringer Ingelheim International GmbH
Successfully represented Boehringer Ingelheim to obtain interim injunction relief against Dr Reddy’s on patents covering the blockbuster medicine Jardiance® (empagliflozin) for treating type 2 diabetes mellitus, heart failure, and chronic kidney disease. This matter was named one of the “Top 20 Cases of 2026” by The Lawyer.
*Matter handled prior to joining Finnegan.
Dr Reddy’s Laboratories (UK) Limited v. Boehringer Ingelheim International GmbH, [2025] EWHC 2834 (Pat), Claim number: HP-2024-000037, Patents Court, Judge Tappin
Related Professionals
- Jin Ooi
- Partner
- London
- +44 20 7864 2821
